Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase NA 1

Status

Completed 4Active not recruiting 4Recruiting 3Terminated 2Unknown 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Genitourinary 4

Conditions

Prostatic Neoplasms 4Solid Tumor, Adult 3Brain Neoplasms 3Squamous Cell Carcinoma of Head and Neck 2Glioma 2Esophageal Neoplasms 2Craniopharyngioma 2Stage I Prostate Adenocarcinoma AJCC v7 1Solid Tumor 1Rhabdomyosarcoma 1Prostate Adenocarcinoma 1Oligodendroglioma 1Neuroectodermal Tumors, Primitive, Peripheral 1Neoplasms, Germ Cell and Embryonal 1Glioblastoma 1Ependymoma 1Desmoplastic Small Round Cell Tumor 1Chordoma 1Chondrosarcoma 1Carcinoma, Squamous Cell 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Intraductal, Noninfiltrating 1Breast Neoplasms 1Breast Carcinoma In Situ 1Astrocytoma 1Anus Neoplasms 1Anatomic Stage I Breast Cancer AJCC v8 1Adenocarcinoma 1

Interventions

enzalutamide 33Abiraterone Acetate 28apalutamide 25Radiotherapy 25Prednisone 25Magnetic Resonance Spectroscopy 25Androgen Antagonists 24Leuprolide 21Radiosurgery 19darolutamide 18Docetaxel 17acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 15Gonadotropin-Releasing Hormone 14gallium 68 PSMA-11 12Specimen Handling 12Goserelin 12pembrolizumab 11Radiotherapy, Intensity-Modulated 11Radiation 11bicalutamide 10abiraterone 10Pluvicto 10Carboplatin 9Brachytherapy 92-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 9relugolix 8luprolide acetate gel depot 8Standard of Care 8Nivolumab 8olaparib 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Active not recruiting × Prostatic Neoplasms × Proton Therapy × Clear all
NCT04190446 2026-06-04

A Study To Evaluate Hypofractionated Proton Therapy Or IMRT For Recurrent, Oligometastatic Prostate Cancer

Mayo Clinic

Phase 2 Active not recruiting
84 enrolled
Genitourinary

Prostatic Neoplasms

NCT01617161 2026-04-24

PARTIQoL

Massachusetts General Hospital

Phase NA Active not recruiting
454 enrolled
Genitourinary

Prostatic Neoplasms

NCT05320406 2026-02-12

REVELUTION

Emory University

Phase 2 Active not recruiting
94 enrolled 13 charts
Genitourinary

Prostatic Neoplasms

NCT03624660 2026-02-10

PR11

University of Florida

Phase 2 Active not recruiting
100 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡